Replies to post #30166 on Intellipharmaceutics International Inc. (IPCI)

[fabius]

I believe mallinckrodt called their man into FDA and asked for a check on ipci Andas and they went for the most likely to be approved in a reasonable time.

I forgot in my previous msg to express my deepest disregard for the keppra and gluco unfruitful approval

[Tekterra]

As far as the deal with MNK and the remaining ANDAs waiting for approval, I am sure MNK would have asked what was the delay. IPCI wanting to keep a good partner would have explained the complications. We haven't been told much by the company so we have no realistic time line on when they might potentially get approval. But, I am sure MNK knew about the complications prior to signing.

In addition to that, MNK is looking to diversify and bring in new source of revenue, because they apparently have issues with their own product. I am sure they have estimates on when they can capitalize on the two other ANDAs pending.

Some times it's very difficult for a small company to try and gain market share. All the big guys will obviously protect their market share.

If I have any advise for Odidi is that he should change his strategy and seek development partner instead of waiting after approval.

True he might get a lesser deal but that's not the point. The point is that his company would fare better with a strong partner to help establish a foothold. Once they get several products out on the market, Odidi would have the resources to pursue his own dreams.